Intravascular Catheter-Related Bloodstream Infection

The Neurohospitalist

Volumn 3, Issue 3, 2013, Pages 144-151

  Shah, Harshal ^a   Bosch, Wendelyn ^a   Hellinger, Walter C ^a   Thompson, Kristine M ^a  

^a MAYO CLINIC   (United States)

Author keywords

clinical specialty; infectious disease medicine; neurocritical care; safety techniques

Indexed keywords

EID: 84992810919     PISSN: 19418744     EISSN: 19418752     Source Type: Journal    
DOI: 10.1177/1941874413476043     Document Type: Article

References (42)

1. Sette P Dorizz RM Azzini AM. Vascular access: an historical perspective from Sir William Harvey to the 1956 Nobel Prize to Andre F. Cournand, Werner Forssman and Dickinson W. Richards. J Vasc Acess. 2012; 13(2):137–144.
2. Mermel LA Allon M Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Disease Society of America. Clin Infectious Dis. 2009; 49(1):1–45.
3. http://www.cdc.gov/hai/pdfs/hai/scott_costpaper.pdf. Accessed September 12, 2012.
4. http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/HospitalAcqCond/downloads/HACFactsheet.pdf. Accessed September 12, 2012.
5. http://www.gpo.gov/fdsys/pkg/FR-2011-05-06/pdf/2011-10568.pdf. Accessed September 12, 2012.
6. Horan TC Andrus M Dudeck MA. CDC/NHSN surveillance definitions of health care-associated infections and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008; 36(5):309–332.
7. Maki DG Kluger DM Crnich CJ. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc. 2006; 81(9):1159–1171.
8. O’Grady NP Alexander RN Burns LA, et al. Guidelines for the prevention of intravascular catheter-related infections, 2011. Am J Infect Control. 2011; 39(4 suppl 1):S1–S34.
9. Beekmann SE Henderson DK. Infections caused by percutaneous intravascular devices. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Disease. Vol 1. 6th ed. Philadelphia, PA: Elsevier; 2005: 3347–3361.
10. Maki DG Ringer M. Evaluation of dressing regimens for prevention of infection with peripheral intravenous catheters: gauze, a transparent polyurethrane dressing and an iodophor-transparent dressing. JAMA. 1987; 258(17):2396–2403.
11. Liñares J Sitges-Serra A Garau J Pérez JL Martín R. Pathogenesis of catheter sepsis: a prospective study with quantitative and semiquantitaive cultures of catheter hub and segments. J Clin Microbiol. 1985; 21(3):357–360.
12. Mermel LA. What is the predominant source of intravascular catheter infections? Clin Infect Dis. 2011; 52(2):211–212.
13. Fitzgerald SF O’Gorman J Morris-Downes MM, et al. A 12-year review of Staphylococcus aureus bloodstream infections in hemodialysis patients: more work to be done. J Hosp Infect. 2011; 79(3):218–221.
14. Pearson ML. Guideline for prevention of intravascular device-related infections. Hospital infection control practices avisory committee. Infect Control Hosp Epidemiol. 1996; 17(7):438–473.
15. Raad I Hachem R Hanna H, et al. Sources and outcomes of bloodstream nfections in cancer patients: the role of central venous catheters. Eur J Clin Microbiol Infect Dis. 2007; 26(8):549–556.
16. Lorente L Jimenez A Santana M, et al. Microorganisms responsible for intravascular catheter-related bloodstream infection according to the catheter site. Crit Care Med. 2007; 35(10):2424–2427.
17. Marra AR Opilla M Edmond MBE Kirby DF. Epidemiology of bloodstream infection in patients receiving long-term parenteral nutrition. J Clin Gastroenterol. 2007; 41(1):19–28.
18. Beck-Sague C Jarvis WR. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National nosocomial infections surveillance system. J Infectious Dis. 1993; 167(5):1247–1251
19. Guembe M Rodriguez-Creixems M Sanchez-Carrillo C Perez-Para A Martin-Rabadan P Bouza E. How many lumens should be cultured in the conservative diagnosis of catheter-related bloodstream infections? Clin Infectious Dis. 2010; 50(12):1575–1579.
20. Marra AR Cal RGR Durao MS, et al. Impact of a program to prevent central-line associated bloodstream infection in the zero tolerance era. Am J Infect Control. 2010; 38(6):434–439.
21. Lobo RD Levin AS Oliveira MS, et al. Evaluation of interventions to reduce catheter-associated bloodstream infection: continuous tailored education versus one basic lecture. Am J Infect Control. 2010; 38(6):440–448.
22. Sannoh S Clones B Munoz J Montecalvo M Parvez B. A multi-modal approach to central venous catheter hub care can decrease catheter-related bloodstream infection. Am J Infect Control. 2010; 38(6):424–429.
23. Peredo R Sabatier C Villagra A, et al. Reduction in catheter-related bloodstream infections in critically ill patients through a multiple system intervention. Eur J Clin Microbiol Infect Dis. 2010; 29(9):1173–1177.
24. Guerin K Wagner J Rains K Bessesen M. Reduction in central line-associated bloodstream infections by implementation of a postinsertion care bundle. Am J Infect Control. 2010; 38(6):430–433.
25. Eggimann P Harbarth S Constantin MN Touveneau S Chevrolet JC Pittet D. Impact of prevention strategy targeted at vascular access care on incidence of infections acquired in intensive care. Lancet. 2000; 355(9218);1864–1868.
26. Berenholtz SM Pronovost PJ Lipsett PA, et al. Eliminating catheter related bloodstream infections in the intensive care unit. Crit Care Med. 2004; 32(10):2014–2020.
27. Costello JM Morrow DF Graham DA Potter-Bynoe G Sandora TJ Laussen PC. Systematic intervention to reduce central line associated bloodstream infection rates in a pediatric cardiac intensive care unit. Pediatrics. 2008; 121(5):915–923.
28. Frankel HL Crede WB Topal JE Roumanis SA Devlin MW Foley AB. Use of corporate Six Sigma performance improvement strategies to reduce catheter related bloodstream infections in a surgical ICU. J Am Coll Surg. 2005; 201(3):349–358.
29. Galpern D Guerrero A Tu A Fahoum B Wise L. Effectiveness of a central line bundle campaign on line associated infections in the intensive care unit. Surgery. 2008; 144(4):492–495.
30. McKee C Berkowitz I Cosgrove SE, et al. Reduction of catheter associated bloodstream infections in pediatric patients: experimentation and reality. Pediatr Crit Care Med. 2008; 9(1):40–46.
31. Kim JS Holtom P Vigen C. Reduction of catheter-related bloodstream infections through the use of a central venous line bundle: epidemiologic and economic consequences. Am J Infect Control. 2011; 39(8):640–646.
32. Furuya EY Dick A Perencevich EN Pogorzelska M Goldmann D Stone PW. Central line bundle implementation in US intensive care units and impact on bloodstream infections. PLoS One. 2011; 6(1):e15452.
33. www.onthecuspstophai.org.
34. Pronovost P Needham D Berenholtz S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med. 2006; 355(26):2725–2732.
35. Srinivasan A Craig M Cardo D. The power of policy change, federal collaboration, and state coordination in healthcare associated infection prevention. Clin Infect Dis. 2012; 55(3): 426–431.
36. Wenzel RP Streed SA. Surveillance and use of computers in hospital infection control. J Hosp Infect. 1989; 13(3):217–229.
37. Sexton DJ Chen LF Anderson DJ. Current definitions of central line-assocated bloodstream infection: is the emperor wearing clothes? Infect Control Hosp Epidemiol. 2010; 31(12):1286–1289.
38. Dudeck MA Horan TC Peterson KD, et al. National healthcare safety network, data summary for 2010, device-associated module. Am J Infect Control. 2011; 39(10):798–816.
39. Gaynes R Richards C Edwards J, et al. Feeding back surveillance data to prevent hospital-acquired infection. Emerg Infectious Dis. 2001; 7(2):295–298.
40. http://www.cdc.gov/nhsn/PDFs/Newsletters/NHSN_NL_OCT_2010SE_final.pdf. Accessed September 12, 2012.
41. http://www.cms.gov/Regulations-and-Guidance/Legislation/CFCsAndCoPs/index.html. Accessed September 12, 2012.
42. http://www.hospitalcompare.hhs.gov/. Accessed September 12, 2012.